Abstract. Ginsenosides are the main biologically active components of ginseng. In this study, seven types of protopanaxadiol ginsenosides were assessed for their antiproliferative activity on the HCT-116 and HT-29 human colorectal cancer cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The experimental results indicated that the native protopanaxadiol ginsenosides Rb1 and Rb2 inhibited the proliferation of the colorectal cancer cells in a dose-dependent manner. The deglycosylation products F2 and CO (from ginsenosides Rb1 and Rb2, respectively) significantly inhibited the growth of the human colorectal cancer cell lines, whereas product C-K (from Rb1 and Rb2) exerted no antiproliferative effects on the cancer cell lines assessed in this study. HT-29 cells were more sensitive to these ginsenosides compared to HCT-116 cells. In addition, the antiproliferative activity of ginsenosides was found to be correlated with the number and type of sugar residues. The potent growth inhibitory effect of protopanaxadiol ginsenosides on cancer cells may be used in the pharmaceutical industry.
Introduction
Ginsenosides are the main active components of ginseng and have various pharmaceutical activities, such as antitumor, antioxidant and neuroprotective activities (1) (2) (3) (4) . Protopanaxadiol ginsenosides Rb1 and Rb2 are abundantly found in ginseng. Protopanaxadiol ginsenosides Rd, F2 and compound K (C-K) are the biotransformation products of Rb1, while CO, CY and C-K are the biotransformation products of Rb2. It has been demonstrated that certain biotransformation products of Rb1 and Rb2 have significant pharmacological activities, such as C-K possessing antiallergic and anti-inflammatory activities (5) (6) (7) (8) . All these protopanaxadiol ginsenosides have the same aglycone (protopanaxadiol); however, the sugar chains are different (Fig. 1 ). The structure-activity relationship of ginsenosides has been investigated, but not fully elucidated (9, 10) . Ginsenosides with fewer sugar residues appear to be more active. In this study, we investigated the activities of seven protopanaxadiol ginsenosides on the inhibition of proliferation of the HCT-116 and HT-29 human colorectal cancer lines. The results may provide information on the antiproliferative activity-structure relationship of ginsenosides.
Materials and methods

Materials.
Standard ginsenosides were purchased from Chengdu Mansite Biotechnology Co., Ltd. (Chengdu, China). The ginsenosides Rb1 and Rb2 and their biotransformation products were prepared as described in our previous study (11) . The metabolites were identified by thin layer chromatography, high-performance liquid chromatography and 13 C-NMR spectrometry. Dulbecco's modified Eagle's medium̸Nutrient Mixture F-12 (DMEM/F12), Iscove's modified Dulbecco's medium (IMDM) and fetal bovine serum (FBS) were purchased from Gibco-BRL (Carlsbad, CA, USA). Penicillin/streptomycin were purchased from the Tianjin Hao Yang biological manufacture Co., Ltd. (Tianjin, China). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was purchased from Sigma (St. Louis, MO, USA). The plates used in this study were purchased from Nalge Nunc International (Rochester, NY, USA). Chemicals used were of analytical grade or higher.
Cell culture. The HCT-116 and HT-29 human colorectal cancer cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). HCT-116 cells were grown in IMDM with 10% heat-inactivated FBS and 100 U̸ml penicillin and streptomycin. HT-29 cells were maintained in DMEM/F12 containing 10% heat-inactivated FBS. The cells were maintained in a humidified chamber of 95% air and 5% CO 2 at 37˚C.
MTT assay. Cells were seeded at a density of 1x10 4 The First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin 130021; 3 School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, P.R. China the addition of ginsenosides. Subsequently, the media were removed and MTT solution (0.5 mg̸ml) was added to each well. The plate was incubated in a humidified atmosphere at 37˚C for 4 h and the media were carefully aspirated. Dimethyl sulfoxide (100 µl) was added and the absorbance was measured at 570 nm by a microplate reader (Bio-Rad, Hercules, CA, USA). The experiments were performed in triplicate.
Statistical analysis. The results were expressed as mean ± standard deviation. Data were analyzed by SPSS software version 17.0 (SPSS Inc., Chicago, IL, USA). Statistical significance was compared between the treatment and the control groups by one-way analysis of variance. The differences were considered statistically significant when P<0.05 and P<0.01 (Fig. 2) . The experiments were performed in triplicate.
Results
Effects of Rb1 and its biotransformation products on cell proliferation. Ginsenoside Rb1 and its biotransformation products Rd, F2 and C-K were assessed for their in vitro antiproliferative activity on two human colon cancer cell lines. The MTT assay results demonstrated that Rb1 exhibited no antiproliferative activity on HCT-116 cells at a low concentration (50 µM). Starting from a dose of 100 µM, Rb1 exhibited a marginal dose-dependent inhibitory effect. At a dose of 250 µM, the inhibitory rate of Rb1 was 27.0% ( Fig. 2A) . The 
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HT-29 cell line was more sensitive to Rb1. Treated with 100 µM or higher concentration of Rb1, the HT-29 cell growth was inhibited in a dose-dependent manner. At the highest dose of 250 µM, the inhibitory rate was 96.4% (Fig. 2B) Effects of Rb2 and its biotransformation products on cell proliferation. Ginsenoside Rb2 and its metabolites CO and CY were assessed for their in vitro antiproliferative activity. As shown in Fig. 2C C-K, with one sugar residue at C-20 of protopanaxadiol, is also a hydrolytic product of Rb2 and it exerted no inhibitory effect on HCT-116 or HT-29 cell growth ( Fig. 2A and B) .
Discussion
Ginsenosides are the major active components of ginseng. It was reported that certain protopanaxadiol ginsenosides, such as Rb1 and Rb2, are transformed into rare bioactive ginsenosides through the hydrolysis of sugar residues, which is usually enabled by glycosidases (11) . In this study, ginsenoside Rb1 and Rb2 and their biotransformation products Rd, F2, C-K (from Rb1), CO and CY (from Rb2), were selected for assessment of their antiproliferative activity on human colon cancer cells. It was observed that the seven ginsenosides possessed the same aglycone but different sugar residues. Therefore, the association between the sugar residues in protopanaxadiol ginsenosides and their antiproliferative activity was elucidated in this study.
Our results demonstrated that the number of sugar residues significantly affected the inhibitory activity. As shown in Fig. 1 , ginsenoside Rb1 and Rb2 have four sugar residues, Rd and CO have three, F2 and CY have two and C-K has one. Taking Rb1 and its deglycosylation products as an example, when the sugar residues decreased from four to one, the antiproliferative activity was significantly altered. Similar effects were observed on HCT-116 and HT-29 cells. Moreover, Rb2 and its metabolites also exhibited different inhibitory effects on the two human colon cancer cells tested. Ginsenoside F2, found in ginseng in minute amounts, was produced by deglycosylation of Rb1 with the catalyzing action of glycosidase. Ginsenoside F2 exerted a more potent inhibitory effect compared to that of Rb1. Similar to F2, the minor ginsenoside CO, which was produced by deglycosylation of Rb2, exerted more potent inhibitory effects compared to those of Rb2. These results indicated that the number of sugar residues may affect the antiproliferative activity of ginsenosides. However, the detailed mechanism needs to be further investigated.
In addition, our results demonstrated that the antiproliferative activity of ginsenosides was also correlated with the type of sugar residue. Ginsenoside Rb1 and Rb2 have a similar structure, with two sugar residues substituted at C-3 and C-20, respectively. The only difference between them is the disaccharide substituted at C-20 [glucose-β-(1→6)-glucosefor Rb1 and arabinose (p)-α-(1→6)-glucose-β-for Rb2]. It was observed that ginsenosides at the same dose but with different terminal sugar residues exhibited different antiproliferative activities. Ginsenoside Rb1 exerted a significant inhibitory effect on HT-29 cell growth in a dose-dependent manner. However, the antiproliferative activity of Rb2 was significantly lower compared to that of Rb1, whereas no dose-dependent inhibitory effect was exerted on HT-29 cells by Rb2. These results indicate that the terminal sugar residue at the C-20 site may affect the inhibitory effects of ginsenosides to a certain extent.
In conclusion, we investigated the inhibitory effects of seven protopanaxadiol ginsenosides on HCT-116 and HT-29 human colorectal cancer cell proliferation. Our results indicate that the number and type of sugar residues may affect the antiproliferative activity of ginsenosides, which may provide useful information on the association between ginsenoside structure and antiproliferative activity.
